目錄:杭州斯達(dá)特生物科技有限公司>>抗體/抗原>>Biosimilar抗體>> S0B0555Anti-PD-L1 Monoclonal Antibody(Atezolizumab)
| 參考價(jià) | ￥ 1750 |
| 參考價(jià) | ￥ 1750 |
更新時(shí)間：2025-07-14 10:14:54瀏覽次數(shù)：58評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息，謝謝!
Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer （NSCLC）, small cell lung cancer （SCLC）, hepatocellular carcinoma and alveolar soft part sarcoma. It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 （PD-L1）.
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)
會(huì)員.png)
1
化工儀器網(wǎng)